Todd Sherer, from the Michael J. Fox Foundation, authored a blog post on the Scientific American website in April. He writes: “Two centuries after its discovery, it’s still incurable—but research is accelerating, with major help from citizen scientists in the patient community.”
STAT News: Before you send your spit to 23andMe, what you need to know
Here’s a very helpful article from yesterday’s STAT News about what 23andMe’s genetic reports can and cannot show…. Full Story>
New York Times: F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers
On April 6, the New York Times reports that the FDA will allow 23andMe to sell genetic tests for disease risk to consumers. According to the article, customers have to specifically ask to be tested for Alzheimer’s and Parkinson’s risk.
EurekAlert! “Journal of Parkinson’s Disease celebrates key breakthroughs”
From the shaking palsy to alpha-synuclein, the stories behind the science from many of the researchers who played key roles in achieving significant milestones are published.
New York Times: Hepatitis Tied to Parkinson’s Risk
Hepatitis infection may increase the risk for Parkinson’s disease, though the reasons for the link remain unknown.
British investigators used records of 100,390 patients hospitalized with various forms of hepatitis or H.I.V. from 1999 to 2011. They compared Parkinson’s incidence in these patients with incidence in more than six million people admitted for medical or surgical conditions like cataracts, knee replacement or varicose veins.
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 46
- Next Page »